Trials / Completed
CompletedNCT04187053
Clinical and Microbiologic Outcomes of aPDT in the Non-surgical Treatment of Implant Inflammation
Clinical and Microbiologic Outcomes of Adjunctive Antimicrobial Photodynamic Therapy in the Non-surgical Treatment of Peri-implant Disease
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- The University of Texas Health Science Center, Houston · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare clinical outcomes (change in bleeding sites (BOP) and probing depth reduction (PPD) after mechanical debridement of implant surfaces at sites exhibiting plaque induced inflammation with or without adjunctive antimicrobial photodynamic therapy (aPDT) and assess the microbiologic profile of plaque samples before and after treatment with or without aPDT samples.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Conventional mechanical therapy | Both experimental and sham arms will receive the Conventional mechanical therapy |
| DRUG | Saline | Sham group will receive saline as a sham for methylene blue |
| DRUG | Methylene Blue | Experimental arm will receive methylene blue |
| DEVICE | Light emitting laser | Experimental arm will receive Light emitting laser |
| DEVICE | Non-light emitting laser | Sham group will receive Non-light emitting laser |
Timeline
- Start date
- 2020-02-14
- Primary completion
- 2022-12-06
- Completion
- 2022-12-06
- First posted
- 2019-12-05
- Last updated
- 2024-02-21
- Results posted
- 2023-12-29
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04187053. Inclusion in this directory is not an endorsement.